Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patients
Open Access
- 24 April 2015
- journal article
- Published by Wiley in Thoracic Cancer
- Vol. 6 (3), 275-287
- https://doi.org/10.1111/1759-7714.12178
Abstract
The neutrophil to lymphocyte ratio (NLR) was recently shown to be a remarkable prognostic factor in tumors. Moreover, some studies have indicated that the combination of NLR and platelet to lymphocyte ratio (PLR) could be a better prognostic factor. As the combined prognostic value of NLR and PLR in non-small cell lung cancer (NSCLC) is not clear, we conducted this study to explore this further. A total of 366 primary NSCLC patients with stage III or IV were finally included. The neutrophil, platelet, and lymphocyte counts were recorded before treatment was initiated. NLR and PLR were calculated and NLR > 2.68 or PLR > 119.50 was defined as elevated. Univariate and multivariate survival analyses were conducted to test their prognostic value. The median of NLR and PLR were 3.14 and 152.63, respectively, in all patients. It was indicated that PLR is linearly associated with NLR. PLR is associated with survival, but is not an independent prognostic factor. Removing NLR, PLR is an independent prognostic factor (overall survival [OS]: hazard ratio [HR] = 1.918, P = 0.003; progression-free survival [PFS]: HR = 1.822, P = 0.007 in condition of NLR ≤ 2.68). It was also indicated that elevated NLR is an independent prognostic factor (OS: HR = 1.778, P = 0.009; PFS: HR = 1.535, P = 0.022) in all patients. PLR is a useful complement of NLR, thus, advanced NSCLC patients could be divided into three prognostic groups prior to treatment: poor: NLR > 2.68; moderate: NLR ≤ 2.68 and PLR > 119.50; and good: NLR ≤ 2.68 and PLR ≤ 119.50.Keywords
Funding Information
- National Natural Science Foundation of China (81302032)
- Natural Science Foundation of Jiangsu Province (BK2011658)
- Natural Science Foundation of Jiangsu Province (BK2011658)
- Natural Scientific Foundation of China Grants (81370172)
This publication has 36 references indexed in Scilit:
- Prognostic Value of PLR in Various Cancers: A Meta-AnalysisPLOS ONE, 2014
- Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancerAsia-Pacific Journal of Clinical Oncology, 2014
- Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers?Asian Pacific Journal of Cancer Prevention, 2014
- Prognostic Significance of Basic Laboratory Methods in Non-Small-Cell-Lung CancerAsian Pacific Journal of Cancer Prevention, 2013
- Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective reviewBMC Cancer, 2013
- Genetic variation in innate immunity and inflammation pathways associated with lung cancer riskCancer, 2012
- Platelets induce neutrophil extracellular traps in transfusion-related acute lung injuryJCI Insight, 2012
- Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective StudyNutrition and Cancer, 2012
- Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancerMedical Oncology, 2012
- Immunity, Inflammation, and CancerCell, 2010